首页> 外国专利> -1 METHOD FOR QUANTIFYING ACTIVE TRANSFORMING GROWTH FACTOR-BETA1 IN BODY FLUID AND METHOD FOR DETECTING CANCER BY USING SAME

-1 METHOD FOR QUANTIFYING ACTIVE TRANSFORMING GROWTH FACTOR-BETA1 IN BODY FLUID AND METHOD FOR DETECTING CANCER BY USING SAME

机译:-1量化体液中活性转化生长因子-BETA1的方法和使用相同方法检测癌症的方法

摘要

The present invention relates to a method for quantitatively and sensitively measuring transforming growth factor-beta 1 (TGF-β1) identified as a significantly increasing factor in a cancer sample. Adding a sample comprising TGF-β1 to a receptor that specifically binds to TGF-β1 to form a TGF-β1-receptor complex and detecting the TGF-β1-receptor complex using a TGF-β1-specific antibody It relates to a method for quantifying TGF-β1. In addition, the present invention relates to a method for testing cancer, comprising quantifying TGF-β1 in human body fluid, a monoclonal antibody having high specificity for TGF-β1, and a hybridoma cell line producing the same.;According to the TGF-β1 quantification method of the present invention, not only can TGF-β1 be sensitively quantitated, but also human body fluids as a source of TGF-β1 can be used to test cancer with high accuracy by sensitive quantification of TGF-β1. can do.
机译:本发明涉及一种定量和灵敏地测量被确定为癌症样品中显着增加的因子的转化生长因子-β1(TGF-β1)的方法。将包含TGF-β1的样品添加至与TGF-β1特异性结合以形成TGF-β1-受体复合物的受体,并使用TGF-β1-特异性抗体检测TGF-β1-受体复合物涉及定量方法TGF-β1。另外,本发明涉及一种测试癌症的方法,该方法包括定量人体液中的TGF-β1,对TGF-β1具有高特异性的单克隆抗体以及产生该抗体的杂交瘤细胞系。本发明的β1定量方法,不仅可以灵敏地定量TGF-β1,而且通过TGF-β1的灵敏定量,作为TGF-β1的来源的人体液体也可以用于高精度地检测癌症。可以做。

著录项

  • 公开/公告号KR100378746B1

    专利类型

  • 公开/公告日2003-04-07

    原文格式PDF

  • 申请/专利权人 한미약품공업 주식회사;

    申请/专利号KR20000018694

  • 发明设计人 진승원;신훈;임창기;

    申请日2000-04-10

  • 分类号G01N33/574;

  • 国家 KR

  • 入库时间 2022-08-21 23:45:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号